Skip to main content

Amanda Cray

Head of Investor Relations

Autolus Therapeutics plc (AUTL)

Equibles does not estimate personal net worth.

Get an email with a short summary when Autolus Therapeutics plc publishes a filing, an earnings call transcript or a press release.

Get AUTL alerts

About Amanda Cray

Amanda Cray is recorded as Head of Investor Relations at Autolus Therapeutics plc (AUTL). Amanda Cray has spoken on 4 earnings calls and 2 other investor events across 1 company, most recently for Autolus Therapeutics plc on May 14, 2026. Autolus Therapeutics plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Autolus Therapeutics plc includes Michael W. Bonney (Chairman and Board Member), Patrick McIlvenny (Chief Accounting Officer), Rob Dolski (Chief Accounting Officer) and 4 others.

Amanda Cray on recent calls

“With me, our Chief Executive Officer, Dr. Christian Aiton, and Chief Financial Officer, Rob Dolsky.”
Head of Investor Relations, Autolus Therapeutics plc Q1 FY2026 Earnings Call ·
“Good afternoon or good evening, everyone, and thank you for joining us for today's presentation. With me, our Chief Executive Officer, Dr. Christian Aitin, and Chief Development Officer, Dr. Matthias Will.”
Head of Investor Relations, Virtual Investor Event: Spotlight on Acute Lymphoblastic Leukemia (ALL) Program ·
“Good afternoon or good evening, everyone, and thank you for joining us for today's presentation. With me, our Chief Executive Officer, Dr. Christian Aitin, and Chief Development Officer, Dr. Matthias Will.”
Head of Investor Relations, VIRTUAL INVESTOR EVENT: SPOTLIGHT ON ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROGRAM ·
“And thank you for joining us on today's call. With me are Chief Executive Officer, Dr. Christian Itin, and Chief Financial Officer, Rob Dolski.”
Head of Investor Relations, Autolus Therapeutics plc Q3 FY2025 Earnings Call ·
“With me are Chief Executive Officer, Dr. Christian Itin, and Chief Financial Officer, Rob Dolski.”
Head of Investor Relations, Autolus Therapeutics plc Q2 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Autolus Therapeutics plc

Recent activity